The company, located in Jiangyin, Jiangsu Province, has developed mass production for a recombinant mussel peptide fused with RGD peptide which acts as a biological glue for wound healing, orthopedic applications etc. For technology development, CA Floudas, a Princeton scholar and member of the US Academy of Engineering, served as a consultant.

China Bio news release, Jan. 8, 2014